Back to the main directory
Press Release
- Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference by GlobeNewsWire
- Lincoln Educational Services Reports Continuing Growth in the Third Quarter with 10.5% Revenue Growth and a 7.1% Increase in Student Starts by GlobeNewsWire
- 23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1 by GlobeNewsWire
- Vertex conclut un partenariat avec Shopify pour simplifier la conformité aux règles fiscales à l'échelle mondiale by GlobeNewsWire
- Provectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting by GlobeNewsWire
- Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting by GlobeNewsWire
- ORYZON to Provide Corporate Progress Updates at Several Events in November by GlobeNewsWire
- Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Long-Term Open-Label Study of DCCR in Prader-Willi Syndrome by GlobeNewsWire
- Post Holdings’ President and CEO Rob Vitale to Take Medical Leave of Absence by GlobeNewsWire
- Post Holdings Provides Preliminary Unaudited Selected Financial Data for Fourth Quarter of Fiscal Year 2023; Issues Fiscal Year 2024 Outlook; Schedules Fourth Quarter and Fiscal Year 2023 Conference Call by GlobeNewsWire
- Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors by GlobeNewsWire
- Anavex Life Sciences Appoints Senior VP of Regulatory Affairs by GlobeNewsWire
- Adverum Biotechnologies Appoints C. David Nicholson, Ph.D. to its Board of Directors by GlobeNewsWire
- Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD by GlobeNewsWire
- Pliant Therapeutics Presentations at the Annual Meeting of the Society for Immunotherapy of Cancer Highlight PLN-101095, A Novel Inhibitor of Integrins αvβ8 and αvβ1 by GlobeNewsWire
- Zscaler Accelerates AI Innovations with Appointments of Two Prominent Tech Industry Disruptors by GlobeNewsWire
- Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States by GlobeNewsWire
- Beyond, Inc., Formerly Overstock.com. Inc., Announces Leadership Transition by GlobeNewsWire
- EQS-News: S.S. Lazio und SPORTTOTAL geben strategische Partnerschaft für Coaching Lösungen und Integration von KI bekannt by EQS Group AG
- CommScope and STMicroelectronics make Matter provisioning for IoT devices secure and easy by GlobeNewsWire
- Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023 by GlobeNewsWire
- BellRing Brands’ Executive Chairman Rob Vitale to Take Medical Leave of Absence by GlobeNewsWire
- Wallbox and Osprey Partner to Expand Reliable Public Charging in the UK by BusinessWire
- Foresight: Eye-Net and SoftBank Corp. Successfully Complete First Phase of Cross-Collision Prevention V2X Project in Japan by GlobeNewsWire
- Vaisala Corporation: Managers’ Transactions – Patala, Irma by GlobeNewsWire